- Home
- FULT vs RLAY Comparison
FULT vs RLAY Comparison
Compare FULT & RLAY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | FULT | RLAY |
|---|---|---|
| Founded | 1882 | 2015 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Banks | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.4B | 4.1B |
| IPO Year | 1995 | 2020 |
Fundamental Metrics
Financial Performance| Metric | FULT | RLAY |
|---|---|---|
| Price | $22.25 | $17.35 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 7 | 13 |
| Target Price | $26.42 | ★ $27.58 |
| AVG Volume (30 Days) | 1.7M | ★ 3.1M |
| Earning Date | 10-21-2026 | 11-05-2026 |
| Dividend Yield | ★ 3.48% | N/A |
| EPS Growth | ★ 32.48 | 31.78 |
| EPS | ★ 1.02 | N/A |
| Revenue | ★ $276,768,000.00 | $15,355,000.00 |
| Revenue This Year | $9.61 | N/A |
| Revenue Next Year | $6.01 | $60.51 |
| P/E Ratio | $21.43 | ★ N/A |
| Revenue Growth | N/A | ★ 53.44 |
| 52 Week Low | $16.86 | $5.95 |
| 52 Week High | $25.23 | $21.27 |
Technical Indicators
Market Signals| Indicator | FULT | RLAY |
|---|---|---|
| Relative Strength Index (RSI) | 40.67 | 42.37 |
| Support Level | $21.68 | $11.68 |
| Resistance Level | $22.49 | $17.40 |
| Average True Range (ATR) | 0.39 | 0.89 |
| MACD | -0.03 | -0.09 |
| Stochastic Oscillator | 40.68 | 19.20 |
Price Performance
Historical ComparisonAbout FULT Fulton Financial Corporation
Fulton Financial Corp is a U.S.-based financial services holding company that operates in five states: Pennsylvania, Delaware, Maryland, New Jersey and Virginia. It offers a range of consumer and commercial banking products and services, such as checking and savings deposit products and loan products. It offers consumer and commercial banking products and services, as well as wealth management products and services. The bank derives its revenue from non-interest income, led by its Wealth Management division.
About RLAY Relay Therapeutics Inc.
Relay Therapeutics Inc is a clinical-stage precision medicine company transforming the drug discovery process and bringing life-changing therapies to patients. The Dynamo platform of the company integrates an array of leading-edge computational and experimental approaches designed to drug-protein targets that have previously been intractable or inadequately addressed. The company is advancing a pipeline of medicine candidates to address targets in precision oncology and genetic disease, including product candidates, RLY-8186, RLY-2608, RLY-4008 and others.